Content validity of patient-reported outcomes for use in lower-risk myelodysplastic syndromes
Abstract Background The lower-risk (low and intermediate-1 risk based on IPSS) myelodysplastic syndrome (MDS) has a negative impact on patients’ health-related quality of life (HRQoL). Patient Reported Outcomes (PROs) instruments, which are used to collect patients’ HRQoL data, should have establish...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2020-08-01
|
Series: | Journal of Patient-Reported Outcomes |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s41687-020-00235-4 |